DACOGEN™ (DECITABINE) FOR INJECTION
MGI PHARMA, Inc. Approved Labeling NDA: 21-790 Dacogen™ (decitabine) for Injection 5/2/2006 Decitabine pharmacokinetics were characterized by
Download DACOGEN™ (DECITABINE) FOR INJECTION
Information
Domain:
Source:
Link to this page:
Documents from same domain
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govEffexor ® (venlafaxine hydrochloride) Tablets Rx only . Suicidality and Antidepressant Drugs Antidepressants increased the risk compared …
Reference ID: 3101735 - Food and Drug …
www.accessdata.fda.govDocetaxel Injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node-positive breast cancer.
Cytotec® - Food and Drug Administration
www.accessdata.fda.govcytotec® (misoprostol) warnings cytotec (misoprostol) administration to women who are pregnant can cause abortion, premature birth, or birth defects.
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govweakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms . FULL …
Namenda XR (memantine hydrochloride) capsules …
www.accessdata.fda.govThe most commonly observed adverse reactions seen in patients administered NAMENDA XR in the controlled clinical trial, defined as those occurring at a frequency of at least 5% in the
FOR INTRAVENOUS USE ONLY - Food and Drug …
www.accessdata.fda.govNDA 50-706/S-022 Page 3 MERREM® I.V. (meropenem for injection) FOR INTRAVENOUS USE ONLY To reduce the development of drug-resistant bacteria and maintain the effectiveness of
NOT FOR USE IN NEONATES CONTAINS BENZYL …
www.accessdata.fda.govDepo-Medrol® methylprednisolone acetate injectable suspension, USP NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL . Not For Intravenous Use . DESCRIPTION
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.accessdata.fda.govDacogen is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and …
Venofer - Food and Drug Administration
www.accessdata.fda.govNDA 21-135/S-017 Page 3 Venofer ® (iron sucrose injection, USP) Rx Only DESCRIPTION Venofer® (iron sucrose injection, USP) is a brown, sterile, aqueous, complex of …
Diphenhydramine Hydrochloride Injection
www.accessdata.fda.govHOW SUPPLIED Diphenhydramine Hydrochloride Injection, USP is a clear and colorless solution available as: 50 mg/mL in a 1 mL prefilled single-use syringe.
Related documents
INJECTABLE MEDICATIONS FEE SCHEDULE …
ahca.myflorida.compage 5 of 5 code description max qty rate comments/notes injectable medications fee schedule oncology 01/01/2018 j9354 ado-trastuzumab emtansine 1mg 400 29.00
DR. REDDY’S LABORATORIES LTD
www.drreddys.comdr. reddy’s laboratories ltd 2015 investor day monday, 18-may-2015 hyderabad, india nyse: rdy, nse: drreddy, bom: 500124, isin: ine089a01023
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu2 1 NAME OF THE MEDICINAL PRODUCT Dacogen 50 mg powder for concentrate for solution for infusion. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial of powder for concentrate for solution for infusion contains 50 mg decitabine.
INDICATIVE LIST of APIs - GLOPEC
www.glopec.com10 Waterloo Court, Thornhill, Ontario, Canada L3t 6l9 Tel: (905) 771-6695 Fax: (905) 771-6696 E-mail: Mail@glopec.com 10/2010May 2011 01 INDICATIVE LIST of APIs
臨 床 藥 Therapeutics of Clinical Drugs 物 治 療 骨髓 …
www.taiwan-pharma.org.tw第31 卷第2期 3 25 骨髓增生不良徵候群 &q £0°) k123 83 臨 床 藥 物 治 20% 療 學 隨著疾病的惡化，骨髓芽細胞之百分比會上 升。兩者最大的差別是 fab 系統界定骨髓